The fibrin sealants global market report 2024 from The Business Research Company provides comprehensive market statistics, including global market size, regional shares, competitor market share, detailed segments, trends, and opportunities. This report offers an in-depth analysis of current and future industry scenarios, delivering a complete perspective for thriving in the industrial automation software market.
Fibrin Sealants Market, 2024 report by The Business Research Company offers comprehensive insights into the current state of the market and highlights future growth opportunities.
Market Size –
The fibrin sealants market size has grown strongly in recent years. It will grow from $1 billion in 2023 to $1.08 billion in 2024 at a compound annual growth rate (CAGR) of 8.1%. The growth in the historic period can be attributed to growth in medical tourism, growth in healthcare infrastructure, rise in elective surgical procedures, increasing prevalence of chronic diseases, and rise in demand for rapid hemostasis solutions.
The fibrin sealants market size is expected to see strong growth in the next few years. It will grow to $1.49 billion in 2028 at a compound annual growth rate (CAGR) of 8.2%. The growth in the forecast period can be attributed to increasing number of cosmetic surgeries, increasing geriatric population, increasing number of CABG, increasing blood-related disorders, and rising number of dental surgeries. Major trends in the forecast period include technological advancements, advanced hemostatic technologies, personalized medicine, digital health technologies, and robotic-assisted surgeries.
Order your report now for swift delivery @
https://www.thebusinessresearchcompany.com/report/fibrin-sealants-global-market-report
Scope Of Fibrin Sealants Market
The Business Research Company’s reports encompass a wide range of information, including:
1. Market Size (Historic and Forecast): Analysis of the market’s historical performance and projections for future growth.
2. Drivers: Examination of the key factors propelling market growth.
3. Trends: Identification of emerging trends and patterns shaping the market landscape.
4. Key Segments: Breakdown of the market into its primary segments and their respective performance.
5. Focus Regions and Geographies: Insight into the most critical regions and geographical areas influencing the market.
6. Macro Economic Factors: Assessment of broader economic elements impacting the market.
Fibrin Sealants Market Overview
Market Drivers –
The increasing number of cosmetic surgeries is expected to propel the growth of the fibrin sealants market going forward. Cosmetic surgeries refer to medical procedures that are primarily focused on enhancing or altering a person’s appearance. Cosmetic surgeries are rising due to societal emphasis on appearance, advancements in surgical techniques, and the growing accessibility of minimally invasive procedures. Fibrin sealants help in cosmetic surgeries, promote faster wound healing, reduce bleeding, and minimize scarring, enhancing surgical outcomes and patient recovery. For instance, in September 2023, according to CosmetAssure, a US-based American Society of Plastic Surgeons, liposuction remained the most in-demand plastic surgery procedure in 2023, with 347,782 procedures performed, a 7% increase from 2022, and tummy tucks also saw a 5% rise, with 170,110 procedures performed. Therefore, the increasing number of cosmetic surgeries drives the fibrin sealants market.
Market Trends –
Major companies operating in the fibrin sealants market are developing hemostatic agents to stop bleeding rapidly upon contact. Hemostatic agents refer to a substance or material used to stop bleeding by promoting blood clotting at a wound or surgical incision site. For instance, in February 2022, Swasth Kare, an India-based hemostatic agent manufacturer, launched SeraSeal from Wortham Laboratories, an India-based company developing hemostatic wound healing and coagulation products. SeraSeal is a fibrin sealant, designed to stop bleeding on contact, achieving hemostasis within seconds, even for arterial hemorrhages. This rapid action can be crucial in emergencies where every second counts. The translucent nature of SeraSeal allows surgeons to visualize the bleeding site clearly, facilitating better decision-making during procedures.
The fibrin sealants market covered in this report is segmented –
1) By Type: Liquid, Patch, Powder
2) By Technology: Autologous Donation, Viral Inactivation, Recombinant Production, Other Technologies
3) By Application: General Surgery, Cardiovascular Surgery, Wound Management, Orthopedic Surgery, Urological Surgeries, Ophthalmic Surgeries, Transplant Surgery, Other Applications
4) By End-User: Hospitals, Ambulatory Surgical Centers, Other End-Users
Get an inside scoop of the fibrin sealants market, Request now for Sample Report @
https://www.thebusinessresearchcompany.com/sample.aspx?id=19434&type=smp
Regional Insights –
North America was the largest region in the fibrin sealants market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the fibrin sealants market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Key Companies –
Major companies operating in the fibrin sealants market are Johnson & Johnson, Takeda Pharmaceutical Company Limited, Asahi Kasei Medical Co. Ltd., Baxter International Inc., CSL Behring, Grifols S.A., Sigma-Aldrich, Nordson Corporation, Integra LifeSciences Corporation, Shanghai RAAS Blood Products Co. Ltd., Mallinckrodt Pharmaceuticals, Biotest AG, LFB Group, Hualan Biological Engineering Inc., Corza Medical, Aesculap Inc., Ethicon Inc., CryoLife Inc., VIVEX Biologics Inc., MediWound Ltd., Cohesion Technologies Inc.
Table of Contents
1. Executive Summary
2. Fibrin Sealants Market Report Structure
3. Fibrin Sealants Market Trends And Strategies
4. Fibrin Sealants Market – Macro Economic Scenario
5. Fibrin Sealants Market Size And Growth
…..
27. Fibrin Sealants Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
